Summary:
- Researchers at the Hollings Cancer Center in South Carolina are conducting clinical trials to test the effectiveness of an mRNA vaccine against COVID-19.
- The vaccine is designed to target specific proteins found on the surface of cancer cells, potentially making it effective in treating certain types of cancer.
- The trials aim to determine if the mRNA vaccine can safely and effectively stimulate the immune system to recognize and attack cancer cells, while also providing protection against COVID-19.